ProSciento, Inc.

We are thrilled to have Stephen Mullennix join ProSciento’s executive team as Chief Financial Officer. Stephen brings a diverse global finance background consisting of over 25 years of operational and transactional experience in biotechnology, eco-infrastructure, and private equity sectors, including roles as CFO, COO and managing partner. Link: https://prosciento.com/prosciento-appoints-stephen-mullenni

To help safeguard the health and wellbeing of our staff and study participants enrolled in studies at our clinical research unit in Chula Vista, we have instituted strict safety measures, including the point of care rapid COVID-19 antigen and antibody testing. We do not view this as a time to relax safety measures. We instead view this as a critical time to enact robust safety protocols and adhere to our corporate value of ‘always looking for a better way’, by striving to be ...a model of the highest quality and safety standards. Safety measures at ProSciento’s CRU include: COVID-19 antigen and antibody testing protocols for staff and study participants Six-foot social distancing and face covering protocol throughout facility Clinic zoning restricted to 10 individuals per area with independent entrance, exit and air flow system MERV-13 HVAC airflow filtration system (HVAC system used in hospital surgical rooms) COVID-19 symptom and exposure monitoring triage prior to entry for all Full personal protective equipment for clinical staff Daily medical grade sanitation of clinic

We’re thrilled to sponsor 14th Annual Diabetes Forum hosted by TCOYD and the diaTribe Foundation. Attended by hundreds of diabetes medical professionals, industry leaders, and patient advocates every June in conjunction with the ADA Scientific Sessions, this year’s virtual event is scheduled for Monday, June 15 at 4:00pm PDT. Visit the website for open registration: https://us02web.zoom.us//9015880/WN_I6vQ2U_2QC6IvUdSvV-aOg

Nearly half of all Americans have at least one risk factor for nonalcoholic steatohepatitis (NASH), yet just 8% of the population are familiar with the disease. Join us as we unite with the Global Liver Institute in recognition and support of #NASHDay to raise awareness for the disease and advance research and collaboration for the development of safe and effective treatments. For more information on fatty liver disease, visit: https://bit.ly/NASHDAY

Fair treatment and equal opportunity for all citizens is part of our fabric and core values at ProSciento. Sharing with you a letter from Dr. Marcus Hompesch, ProSciento’s founder and CEO, to employees.

The American Diabetes Association hosted a conversational-style virtual town hall meeting this week, titled COVID-19 & Inpatient Care for People with Diabetes. ADA President Dr. Bob Eckel is joined by medical experts Dr. Irl Hirsch, Dr. Jane Seley, Dr. Shivani Agarwal, Melanie Mabrey and Jennifer Clements to discuss in-patient COVID-19 care for individuals with diabetes. Check it out at https://professional.diabetes.org//american-diabetes-assoc

During these challenging and uncertain times, we are grateful for our tremendous team, partners and clients as we work together swiftly and responsibly to ensure patient safety and treatment continuity in response to the impacts of COVID-19. Together, we remain committed to our mission of finding new treatments for diabetes, NASH, obesity and related metabolic diseases. To learn about our COVID-19 response and preparedness, please visit: https://prosciento.com/covid-19/.

Donating blood is a commendable act of kindness and can make difference in someone’s life during this corona virus outbreak. The American Red Cross is facing a severe blood shortage due to an unprecedented number of blood drive cancellations. If you are a healthy volunteer, who hasn’t traveled internationally in last 28 days, then you can visit Red Cross website and schedule an appointment to provide lifesaving blood products to patients. For more information and making an appointment, please visit: https://lnkd.in/djVuV_X #donations #redcross

Thank you to healthcare professionals, first responders and all individuals who are working tirelessly to provide medical care for patients diagnosed with COVID-19.

Download the fact sheet to gain insights on how ProSciento provides scientific and operational expertise in the design and management of all facets of obesity-related clinical drug development. Visit: http://bit.ly/ObesityFactsheet #obesity #factsheet #drugdevelopment

Our ProSciento Tour de Cure team is thrilled to help the ADA reach their goal today of $100,000 to fight diabetes! We’ll see you at the Tour de Cure event in San Diego on April 4. Look for us at the ProSciento tent and come by for some swag. American Diabetes Association #TourDeCure

World Obesity Day is observed on March 4 to drive global solutions to the obesity crisis by raising awareness and promoting policies on obesity treatment and its prevention. #WorldObesityDay